Breaking News Instant updates and real-time market news.

JCOM

j2 Global

$84.41

-0.25 (-0.30%)

, QTM

Quantum

$0.87

0.0001 (0.01%)

04:55
01/12/17
01/12
04:55
01/12/17
04:55

Needham to hold a conference

19th Annual Growth Conference is being held in New York on January 10-12.

JCOM

j2 Global

$84.41

-0.25 (-0.30%)

QTM

Quantum

$0.87

0.0001 (0.01%)

RESN

Resonant

$4.56

-0.04 (-0.87%)

UEIC

Universal Electronics

$67.85

1.4 (2.11%)

AMBA

Ambarella

$51.00

-2.71 (-5.05%)

ESE

Esco Technologies

$58.05

0.85 (1.49%)

NTNX

Nutanix

$29.96

0.78 (2.67%)

PCTY

Paylocity

$33.37

1.02 (3.15%)

VPG

Vishay Precision

$18.45

-0.2 (-1.07%)

JACK

Jack in the Box

$109.38

-0.61 (-0.55%)

SWIR

Sierra Wireless

$16.65

0.3 (1.83%)

UTEK

Ultratech

$25.01

0.34 (1.38%)

AXTI

AXT, Inc.

$5.80

0.5 (9.43%)

ESIO

Electro Scientific

$6.51

0.1 (1.56%)

MARK

Remark Media

$3.29

-0.13 (-3.80%)

GILT

Gilat Satellite

$5.30

0.22 (4.33%)

GIG

GigPeak

ACLS

Axcelis

$16.50

1.6 (10.74%)

KRNT

Kornit Digital

$16.80

2.85 (20.43%)

EXFO

EXFO Inc.

$4.70

0.1 (2.17%)

TDY

Teledyne

$123.01

0.27 (0.22%)

CY

Cypress Semiconductor

$11.56

0.03 (0.26%)

WIX

Wix.com

$51.00

2.5 (5.15%)

PLCM

bought by Siris Capital 9/16

RDCM

Radcom

$18.65

-0.1 (-0.53%)

SYNT

Syntel

$20.93

0.01 (0.05%)

  • 12

    Jan

  • 17

    Jan

  • 18

    Jan

  • 19

    Jan

  • 23

    Jan

  • 24

    Jan

  • 14

    Feb

  • 14

    Feb

  • 27

    Feb

JCOM j2 Global
$84.41

-0.25 (-0.30%)

10/24/16
LEER
10/24/16
DOWNGRADE
Target $10.5
LEER
Market Perform
Everyday Health downgraded to Market Perform from Outperform at Leerink
Leerink analyst David Larsen downgraded Everyday Health (EVDY) to Market Perform from Outperform after the company announced that it has entered into a definitive agreement to merge with Ziff Davis, the digital media division of j2 Global (JCOM) in an all cash deal. The analyst also lowered his price target on the stock to $10.50 from $13, as he expects the shares to trade at or around the deal price.
10/21/16
SBSH
10/21/16
DOWNGRADE
Target $10.5
SBSH
Neutral
Everyday Health downgraded to Neutral from Buy at Citi
Citi analyst Mark Kelley downgraded Everyday Health (EVDY) to Neutral after the company announced an agreement with j2 Global's (JCOM) Ziff Davis to be acquired for $10.50 per share in cash. The analyst views the price as fair and does not expect WebMD (WBMD) to come in with a competing bid.
08/31/16
08/31/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BTIG initiated coverage of Juno Therapeutics (JUNO) with a Sell rating, saying the firm is "generally skeptical of current investor expectations for the CD19 CAR T market." The firm has a fair value estimate on Juno of $23 per share. 2. JPMorgan analyst Alex Yao assumed coverage of Sohu.com (SOHU) with an Underweight rating and $40 price target. The rating is unchanged and the price target is lowered from $47. The company will find it difficult to come up with new initiatives to address the continued decline in games revenue, Yao tells investors in a research note. 3. JPMorgan's Yao assumed coverage of SINA (SINA) with an unchanged Overweight rating and $123 price target. 4. Jefferies analyst Jason Kupferberg started First Data (FDC) with a Buy rating and $16.50 price target. Growth in the company's domestic merchant processing segment is set to inflect, the analyst tells investors in a research note. 5. Baird analyst William Power initiated j2 Global (JCOM) with an Outperform rating and $83 price target, citing its attractive valuation, strong free cash flow, consistent margin expansion, the growth in digital media, and its disciplined acquisition strategy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/31/16
BARD
08/31/16
INITIATION
Target $83
BARD
Outperform
j2 Global initiated with an Outperform at Baird
Baird analyst William Power initiated j2 global with an Outperform rating and $83 price target. The analyst cited its attractive valuation, strong free cash flow, consistent margin expansion, the growth in digital media, and its disciplined acquisition strategy.
QTM Quantum
$0.87

0.0001 (0.01%)

10/06/16
LSCM
10/06/16
NO CHANGE
Target $1.5
LSCM
Buy
Quantum price target raised to $1.50 from $1.00 at Lake Street
Lake Street analyst Eric Martinuzzi raised his price target on Quantum to $1.50 from $1.00, citing the company's preannouncement of higher than expected Q2 revenue, which he said continues its recent "encouraging revenue trend reversal." The firm keeps a Buy rating on Quantum shares.
RESN Resonant
$4.56

-0.04 (-0.87%)

UEIC Universal Electronics
$67.85

1.4 (2.11%)

11/07/16
RILY
11/07/16
UPGRADE
Target $73.5
RILY
Buy
Universal Electronics upgraded to Buy from Neutral at B. Riley
B. Riley analyst Ian Corydon upgraded Universal Electronics to Buy with an unchanged price target of $73.50 following the company's Q3 results.
08/18/16
LSCM
08/18/16
INITIATION
Target $87
LSCM
Buy
Universal Electronics initiated with a Buy at Lake Street
Lake Street analyst Jaeson Schmidt started Universal Electronics with a Buy rating and $87 price target. The company is positioned to benefit as cable and satellite providers roll out next-gen platforms, Schmidt tells investors in a research note.
07/22/16
07/22/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. General Electric (GE) initiated with a Sell at Standpoint Research. 2. Williams (WMB) and Williams Partners (WPZ) resumed with a Neutral at Citi. 3. Nevro (NVRO) initiated with an Overweight at Piper Jaffray. 4. Universal Electronics (UEIC) initiated with a Buy at Sidoti. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/22/16
SIDC
07/22/16
INITIATION
Target $98
SIDC
Buy
Universal Electronics initiated with a Buy at Sidoti
Sidoti analyst Gregory Burns initiated Universal Electronics with a Buy and $98 price target.
AMBA Ambarella
$51.00

-2.71 (-5.05%)

10/12/16
ADAM
10/12/16
NO CHANGE
Target $87
ADAM
Buy
Ambarella leading technology position remains intact, says Canaccord
Canaccord analyst Matthew Ramsay said Ambarella's leading technology position remains intact. He noted the company has several growing end markets - including wearables, security, automotive and drone cameras - and believes long-term investors will be rewarded with the new design ramp. Ramsay reiterated his Buy rating and raised his price target to $87 from $86 on Ambarella shares.
12/02/16
ROTH
12/02/16
NO CHANGE
Target $70
ROTH
Buy
Ambarella price target lowered to $70 from $80 at Roth Capital
Roth Capital analyst Suji Desilva lowered his price target for Ambarella to $70 from $80 following results for the quarter. While results exceeded guidance, and represented a new quarterly record, the analyst notes guidance was cautious regarding holiday sell-through on Ambarella's increasingly consumer-centric program ramps. He reiterates a Buy rating on the shares.
11/04/16
ADAM
11/04/16
NO CHANGE
Target $87
ADAM
Buy
Ambarella weakness a buying opportunity, says Canaccord
Canaccord analyst Matthew Ramsay noted Ambarella (AMBA) shares moved lower following a disappointing holiday sales outlook from GoPro (GPRO), but said the weakness is a buying opportunity. Ramsay reiterated his Buy rating and $87 price target on Ambarella shares, saying that the company's road map is being driven by the automotive industry, professional drones, and enterprise security cameras more than consumer action cameras.
09/28/16
ROTH
09/28/16
INITIATION
Target $80
ROTH
Buy
Ambarella initiated with a Buy at Roth Capital
Roth Capital analyst Suji Desilva initiated Ambarella with a Buy rating and an $80 price target.
ESE Esco Technologies
$58.05

0.85 (1.49%)

NTNX Nutanix
$29.96

0.78 (2.67%)

01/11/17
FBNS
01/11/17
INITIATION
Target $30
FBNS
Sector Perform
Nutanix initiated with a Sector Perform at FBN Securities
FBN Securities analyst Shebly Seyrafi initiated Nutanix with a Sector Perform and a $30 price target.
01/11/17
OPCO
01/11/17
NO CHANGE
Target $38
OPCO
Outperform
Nutanix technology remains underappreciated, says Oppenheimer
Oppenheimer analyst Ittai Kidron believes investors underappreciate Nutanix's technology and sustainable HCI leadership, which he expects to drive revenue upside in 2017 as well as steady bottom line improvement. The analyst also says that margins could also see an unexpected upside as sales scale and software grows. He reiterates an Outperform rating and $38 price target on the shares.
11/30/16
NEED
11/30/16
NO CHANGE
Target $36
NEED
Buy
Nutanix should be bought on any weakness, says Needham
Needham analyst Richard Kugele notes that Nutanix beat expectations for the quarter on every single metric. With guidance above consensus as well, the analyst believes business momentum has continued at this "innovative disruptive company." Kugele would use any pullbacks in the name to build/add to positions. He reiterates a Buy rating and $36 price target on the shares.
12/12/16
JMPS
12/12/16
NO CHANGE
JMPS
Nutanix market 'gaining momentum,' says JMP Securities
After attending a Gartner conference, JMP Securities analysts John Lucia and Erik Suppiger say that Nutanix (NTNX) is a leader in the hyperconverged infrastructure, or HCI, market and that awareness of the market "is expanding rapidly." The analysts add that Nutanix's customers appear to be deploying its HCI product more widely in their companies. They believe that the recent decline in Nutanix ha created a buying opportunity, and they reiterate a $38 price target and an Outperform rating on the shares.
PCTY Paylocity
$33.37

1.02 (3.15%)

11/04/16
FANA
11/04/16
UPGRADE
Target $48
FANA
Overweight
Paylocity upgraded to Overweight at First Analysis
As previously reported, First Analysis analyst Corey Greendale upgraded Paylocity to Overweight from Equal-Weight, saying he believes the company's "disappointing" December-quarter growth guidance is "explainable and conservative" and not representative of the company's true growth potential. Greendale keeps a $48 price target on Paylocity shares.
12/01/16
OPCO
12/01/16
INITIATION
OPCO
Paylocity initiated with a Perform at Oppenheimer
11/07/16
BARD
11/07/16
NO CHANGE
Target $44
BARD
Outperform
Paylocity price target lowered to $44 from $52 at Baird
Baird analyst Mark Marcon lowered his price target on Paylocity to $44 from $52 to reflect lowered guidance following Q1 results. The company lowered guidance as they saw decelerating revenues against difficult comps. Marcon said he can see a further pullback in the shares and recommends a disciplined approach to buying the shares. Marcon maintained his Outperform rating on Paylocity shares.
11/14/16
DBAB
11/14/16
NO CHANGE
Target $55
DBAB
Buy
Paylocity pullback brings attractive entry point, says Deutsche Bank
Deutsche Bank analyst Nandan Amladi believes the recent pullback in shares of Paylocity creates an attractive entry point. Fears of the Affordable Care Act being repealed by the incoming administration have pressured several healthcare software names this past week, Amladi tells investors in a research note. The analyst thinks FY19 estimates are achievable even if the ACA benefit is removed. Amladi reiterates a Buy rating on Paylocity with a $55 price target.
VPG Vishay Precision
$18.45

-0.2 (-1.07%)

JACK Jack in the Box
$109.38

-0.61 (-0.55%)

10/24/16
GSCO
10/24/16
INITIATION
Target $88
GSCO
Sell
Jack in the Box initiated with a Sell at Goldman
Goldman Sachs analyst Karen Holthouse started Jack in the Box with a Sell rating and $88 price target. Taco Bell's focus on $1 price points and growing breakfast creates near-term risks to comp trends while Qdoba continues to struggle, Holthouse tells investors in a research note.
11/23/16
BARD
11/23/16
NO CHANGE
Target $125
BARD
Outperform
Jack in the Box near-term risk/reward favorable, says Baird
Baird analyst David Tarantino noted Jack in the Box reported fairly solid Q4 results and provided a positive outlook. The company also showed signs of improving comps momentum as well as benefits from key value-creating strategies. Tarantino said the near-term risk/reward is favorable at current levels, reiterated his Outperform rating and raised his price target to $125 from $120 on Jack in the Box shares.
11/25/16
JEFF
11/25/16
NO CHANGE
Target $121
JEFF
Buy
Jack in the Box price target raised to $121 from $112 at Jefferies
Jefferies analyst Alexander Slagle raised his price target for Jack in the Box to $121 following the company's Q4 results. The shares are attractively valued for some of the best same-store-sales and earnings growth in the industry, Slagle tells investors in a research note. Jack in the Box trends are impressive while Qdoba is holding up well despite tough compares, the analyst contends. He reiterates a Buy rating on the shares.
11/22/16
OPCO
11/22/16
NO CHANGE
Target $115
OPCO
Outperform
Oppenheimer remains bullish on Jack in the Box after quarterly results
Following Jack in the Box's earnings release, Oppenheimer analyst Brian Bittner says he would buy any near-term dip. The analyst believes management's initial 2017 EPS outlook appears "conservatively, and says he is bullish on the stock given the attractive valuation, conservative EPS guidance, "solid" sales trends and an improving financial model. He reiterates an Outperform rating and $115 price target on the shares.
SWIR Sierra Wireless
$16.65

0.3 (1.83%)

01/19/16
01/19/16
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aaron's (AAN) upgraded to Strong Buy from Market Perform at Raymond James... Allstate (ALL) upgraded to Outperform from Neutral at Macquarie... Amedisys (AMED) upgraded to Buy from Neutral at Mizuho... Applied Materials (AMAT) upgraded to Buy from Outperform at CLSA... AstraZeneca (AZN) upgraded to Equal Weight from Underweight at Barclays... Beacon Roofing (BECN) upgraded to Outperform from Market Perform at William Blair... Burberry (BURBY) upgraded to Buy from Neutral at UBS... Burlington Stores (BURL) upgraded to Buy from Hold at BB&T... Campbell Soup (CPB) upgraded to Neutral from Underweight at JPMorgan... Carrizo Oil & Gas (CRZO) upgraded to Buy from Accumulate at KLR Group... China Mobile (CHL) upgraded to Buy from Hold at Deutsche Bank... Cypress Energy (CELP) upgraded to Strong Buy from Outperform at Raymond James... D.R. Horton (DHI) upgraded on entry level consumer focus at Sterne Agee CRT... Eaton Vance (EV) upgraded to Neutral from Negative at Susquehanna... Exelixis (EXEL) upgraded to Outperform from Market Perform at Leerink... Fifth Street Finance (FSC) upgraded to Outperform from Market Perform at Wells Fargo... Julius Baer (JBAXY) upgraded to Buy from Hold at Berenberg... Kite Pharma (KITE) upgraded to Outperform from Market Perform at FBR Capital... Lennar (LEN) upgraded on results outlook at Sterne Agee CRT... Matador (MTDR) upgraded to Accumulate from Hold at KLR Group... McDonald's (MCD) upgraded to Buy from Neutral at BTIG... Michael Kors (KORS) upgraded to Neutral from Underweight at Piper Jaffray... Microchip (MCHP) upgraded to Overweight from Equal Weight at Morgan Stanley... New York Community Bancorp (NYCB) upgraded to Market Perform at FBR Capital... Pandora (P) upgraded to Neutral from Sell at BTIG... Penn National (PENN) upgraded to Outperform from Market Perform at Telsey Advisory... Procter & Gamble (PG) upgraded on results outlook, multiple expansion at Stifel... Regeneron (REGN) upgraded to Buy from Neutral at Roth Capital... Regions Financial (RF) upgraded to Overweight from Neutral at Piper Jaffray... Retail Properties of America (RPAI) upgraded to Buy from Hold at Deutsche Bank... Shake Shack (SHAK) upgraded to Outperform from Market Perform at William Blair... Shopify (SHOP) upgraded to Overweight from Equal Weight at Morgan Stanley... Sierra Wireless (SWIR) upgraded to Outperform from Market Perform at Northland... Silgan Holdings (SLGN) upgraded to Outperform from Market Perform at Wells Fargo... Skyworks (SWKS) upgraded to Buy from Hold at Needham... Sunstone Hotel (SHO) upgraded to Buy on valuation at Evercore ISI... Tenet (THC) upgraded to Buy from Neutral at Mizuho... United Financial (UBNK) upgraded to Overweight from Neutral at Piper Jaffray... Web.com (WEB) upgraded to Buy from Hold at Craig-Hallum... Wolseley (WOSYY) upgraded to Equal Weight from Underweight at Morgan Stanley... adidas (ADDYY) upgraded to Neutral from Underperform at Credit Suisse.
08/04/16
08/04/16
NO CHANGE

On The Fly: After Hours Movers
UP AFTER EARNINGS: Pacific Biosciences (PACB), up 17%... MasTec (MTZ), up 9.6%... Aratana Therapeutics (PETX), up 9.2%... Lion's Gate (LGF), up 6.4%... Priceline (PCLN), up 5.7%... Ubiquiti (UBNT), up 5.5%... MercadoLibre (MELI), up 4.1%... Organovo (ONVO), up 3.9%... Kraft Heinz (KHC), up 3.3%... EOG Resources (EOG), up 2.8%... Monster Beverage (MNST), up 1.2%... TASER (TASR), up 1.2%... Take-Two (TTWO), up 0.9%... Activision Blizzard (ATVI), up 1%... BioMarin (BMRN), up 0.4%. ALSO HIGHER: Egalet (EGLT), up 31.2% after the company announced that an FDA advisory committee recommended approval of its ARYMO ER drug... Rackspace (RAX), up 17.6% after the Wall Street Journal reported that the company was near a takeover deal with a private equity buyer... Osiris (OSIR), up 8.5% after it said that the manuscript from its prospective trial using Grafix was published. DOWN AFTER EARNINGS: Hortonworks (HDP), down 26.2%... PDL BioPharma (PDLI), down 17.5%... FireEye (FEYE), down 15.8%... Sierra Wireless (SWIR), down 15.6%... Aquinox (AQXP), down 14.7%... Zynga (ZNGA), down 9.4%... Universal Display (OLED), down 8.2%... Weight Watchers (WTW), down 7.6%... Zillow Group (Z, ZG), down 5.5%... Arista Networks (ANET), down 4.5%... Noodles & Company (NDLS), down 4.3%... Merrimack (MACK), down 1.7%... Bankrate (RATE), down 1.7%.
08/05/16
CIBC
08/05/16
DOWNGRADE
CIBC
Underperformer
Sierra Wireless downgraded to Underperformer from Sector Performer at CIBC
01/19/16
NORL
01/19/16
UPGRADE
Target $23
NORL
Outperform
Sierra Wireless upgraded to Outperform from Market Perform at Northland
Northland analyst Michael Latimore upgraded Sierra Wireless to Outperform citing the stock's 70% decline since his downgrade as well as channel checks which indicated solid end market trends. The analyst keeps a $23 price target for the shares.
UTEK Ultratech
$25.01

0.34 (1.38%)

04/22/16
DADA
04/22/16
DOWNGRADE
DADA
Neutral
Ultratech downgraded on margins, valuation at DA Davidson
As noted earlier, DA Davidson downgraded Ultratech to Neutral from Buy. The firm downgraded the stock based on valuation and lower than expected margins. Target remains $24.
04/21/16
DADA
04/21/16
DOWNGRADE
DADA
Neutral
Ultratech downgraded to Neutral from Buy at DA Davidson
AXTI AXT, Inc.
$5.80

0.5 (9.43%)

05/03/16
CHLM
05/03/16
UPGRADE
CHLM
Buy
AXT, Inc. upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst Richard Shannon upgraded AXT, Inc to Buy and increased its price target to $4.25 from $2.75 following the Q1 upside driven by InP which continues to benefit from increasing demand from the optical communications market. The analyst expects the improvement to be sustainable for a reasonable investment horizon and sees visibility into growth and GM improvement.
05/03/16
05/03/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AXT, Inc. (AXTI) upgraded to Buy at Craig-Hallum by analyst Richard Shannon following the Q1 upside driven by InP which continues to benefit from increasing demand from the optimal communications market. The analyst expects the improvement to be sustainable for a reasonable investment horizon and sees visibility into growth and GM improvement. 2. Midcoast Energy (MEP) upgraded to Neutral at Credit Suisse by analyst John Edwards, who cited the company's announcement of a strategic review. 3. Republic Services (RSG) upgraded to Overweight at Barclays with analyst Jon Windham saying he expects the waste disposal sector to experience continued per share profit growth. 4. Superior Energy (SPN) upgraded to Buy at Citi by analyst Scott Gruber, who said the company's strategy shift to potentially expand the frac business could be a "material catalyst" for the shares. 5. Intevac (IVAC) upgraded to Buy from Hold at Maxim. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/16
NEED
07/28/16
UPGRADE
NEED
Buy
AXT, Inc. upgraded to Buy from Hold at Needham
ESIO Electro Scientific
$6.51

0.1 (1.56%)

02/03/16
02/03/16
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADT Corp. (ADT) upgraded to Equal Weight from Underweight at Morgan Stanley... Badger Meter (BMI) upgraded to Outperform from Neutral at Baird... Boot Barn (BOOT) upgraded to Buy from Neutral at B. Riley... Chipotle (CMG) upgraded to Outperform from Market Perform at Wells Fargo... Dow Chemical (DOW) upgraded to Top Pick from Outperform at RBC Capital... Electro Scientific (ESIO) upgraded to Buy from Hold at Needham... Hyatt (H) upgraded to Outperform from Market Perform at Wells Fargo... Intel (INTC) upgraded to Neutral from Sell at Goldman... Mallinckrodt (MNK) upgraded to Buy from Neutral at Mizuho... Michael Kors (KORS) upgraded to Neutral from Sell at Citi... NeoPhotonics (NPTN) upgraded to Strong Buy from Outperform at Raymond James... PGT, Inc. (PGTI) upgraded to Buy from Hold at Craig-Hallum... Performance Sports Group (PSG) upgraded to Outperform from Neutral at Wedbush... Superior Drilling (SDPI) upgraded to Buy from Neutral at Roth Capital... Syntel (SYNT) upgraded to Buy from Hold at Maxim... Valley National (VLY) upgraded to Overweight from Neutral at Piper Jaffray... Willis Towers Watson (WLTW) upgraded to Buy from Neutral at SunTrust.
08/03/16
NEED
08/03/16
DOWNGRADE
NEED
Hold
Electro Scientific downgraded to Hold from Buy at Needham
08/03/16
NEED
08/03/16
DOWNGRADE
NEED
Hold
Electro Scientific downgraded to Hold at Needham
As previously reported, Needham analyst James Ricchiuti downgraded Electro Scientific to Hold from Buy, saying that acceptance to new products has been encouraging but is unlikely to offset the slowdown in the company's core business, which could persist for several quarters. Electro Scientific's gradual turnaround, which produced improvement in profitability over the past year, has "hit a snag" after bookings fell 45% in Q1, the analyst tells investors in a research note.
08/22/16
DADA
08/22/16
NO CHANGE
DADA
Electro Scientific new CEO has good record, says DA Davidson
DA Davidson analyst Thomas Diffely says that Electro Scientific's new CEO, Michael Burger, has "a strong history" of turning around struggling companies. The analyst notes that Burger has previously headed a printed circuit board manufacturer and says that he "maximized shareholder value at the last two public companies he ran." The analyst reiterates a Buy rating on Electro Scientific.
MARK Remark Media
$3.29

-0.13 (-3.80%)

10/12/16
ROTH
10/12/16
INITIATION
Target $8.5
ROTH
Buy
Remark Media initiated with a Buy at Roth Capital
Roth Capital analyst Darren Aftahi started Remark Media with a Buy rating and $8.50 price target as he believes it represents a compelling portfolio of assets in the Internet sector, with high levels of exposure to the coveted Millennial demographic in both China and the U.S.
01/03/17
ROTH
01/03/17
NO CHANGE
Target $8.5
ROTH
Buy
Alibaba partnership further validates Remark Media KanKan, says Roth Capital
Roth Capital analyst Darren Aftahi says Remark Media's (MARK) partnership with Alibaba (BABA) Cloud for artificial intelligence further deepens its relationship with the latter. The analyst believes the opportunity is incremental to its credit scoring product with Alibaba and allows Remark Media addition monetization opportunities within Alibaba Cloud's ecosystem. While Aftahi expects P&L impact could be later in 2017, it gives him further confidence that his $5M KanKan 2017 revenue estimate could prove conservative. He reiterates a Buy rating and $8.50 on Remark Media's shares.
GILT Gilat Satellite
$5.30

0.22 (4.33%)

GIG GigPeak

06/14/16
NEED
06/14/16
INITIATION
Target $3.5
NEED
Buy
GigPeak initiated with a Buy at Needham
Needham analyst N. Quinn Bolton initiated GigPeak with a Buy and $3.50 price target.
06/16/16
RAJA
06/16/16
INITIATION
Target $3.5
RAJA
Outperform
GigPeak initiated with an Outperform at Raymond James
Raymond James analyst J. Steven Smigie initiated GigPeak with an Outperform and $3.50 price target.
10/31/16
NEED
10/31/16
NO CHANGE
NEED
Needham remains bullish on Optical Sector
Needham analyst Alex Henderson believes the "Optical Super Cycle" is going full steam ahead and strongly reiterates his bullish view on the Optical Sector. The analyst believes that most of the angst over the last week around the optical sector is a non-issue. Henderson is an aggressive buyer on weakness of Lumentum (LITE), NeoPhotonics (NPTN), Oclaro (OCLR), and Inphi (IPHI). Finisar (FNSR), Fabrinet (FN), II-VI (IIVI), GigPeak (GIG) and MACOM (MTSI) are also strong recommendations, he added. Further, Henderson believes Acacia Communications (ACIA) has "way overcorrected," and thinks it can rebound on a stronger Q4 outlook and upside to 2017 numbers.
04/05/16
ROTH
04/05/16
NO CHANGE
Target $7
ROTH
Buy
Roth Capital positive on GigOptix acquisition of Magnum Semiconductor
Roth Capital analyst Krishna Shankar believes that GigOptix's "transformative acquisition" of Magnum Semiconductor positions the new company, renamed GigPeak, to emerge as a key provider of semiconductor system-on-chip and software platforms for efficient, high quality streaming of data and video. Shankar reiterates a Buy rating and raised his price target on GigOptix's shares to $7 from $5.
ACLS Axcelis
$16.50

1.6 (10.74%)

KRNT Kornit Digital
$16.80

2.85 (20.43%)

01/22/16
ADAM
01/22/16
NO CHANGE
Target $20
ADAM
Buy
Kornit Digital should be bought ahead of results, says Canaccord
Canaccord recommends investors buy Kornit Digital ahead of Q4 results as they believe the company is well positioned to deliver strong growth in 2016 despite current macro headwinds. The firm kept its estimates intact and remains convinced management's long-term model is achievable. Canaccord reiterated its Buy rating and $20 price target on Kornit Digital shares.
EXFO EXFO Inc.
$4.70

0.1 (2.17%)

12/14/16
JPMS
12/14/16
NO CHANGE
Target $11
JPMS
Overweight
JPMorgan sees 88% upside for Viavi should it buy Ixia
JPMorgan analyst Rod Hall believes an acquisition of Ixia (XXIA) could drive shares of Viavi (VIAV) 88% higher due to deal accretion. Reuters on December 2 reported that Ixia is exploring options, including a possible sale. Ixia presents more upside potential for Viavi than other possible takeout candidates such as EXFO (EXFO), Hall tells investors in a research note. The analyst sees 34% upside for Viavi on a standalone basis and 51% upside from a takeover of EXFO. He continues to believe Viavi is likely to benefit from 3D sensing content in Apple's (AAPL) iPhone. Winning 3D sensing filters on the iPhone could result in more than $50M in incremental revenue for the company in 2017, Hall estimates. He keeps an Overweight rating on Viavi with an $11 price target.
TDY Teledyne
$123.01

0.27 (0.22%)

07/06/16
KING
07/06/16
DOWNGRADE
KING
Neutral
Teledyne downgraded to Neutral from Buy at CL King
CY Cypress Semiconductor
$11.56

0.03 (0.26%)

12/20/16
DTFT
12/20/16
NO CHANGE
DTFT
Cypress Semiconductor mentioned as potential M&A target at Detwiler Fenton
12/19/16
BOFA
12/19/16
INITIATION
Target $16
BOFA
Buy
Cypress Semiconductor initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Vivek Arya initiated Cyrpess Semiconductor with a Buy and a $16 price target saying it is an attractive turnaround situation with potential for double digit earnings growth through execution improvements and a more friendly pricing environment.
12/16/16
LOOP
12/16/16
INITIATION
Target $14
LOOP
Buy
Cypress Semiconductor initiated with a Buy at Loop Capital
Loop Capital analyst Betsy Van Hees started Cypress Semiconductor with a Buy rating and $14 price target.
12/05/16
LOOP
12/05/16
INITIATION
Target $14
LOOP
Buy
Cypress Semiconductor initiated with a Buy at Loop Capital
Loop Capital initiates Cypress Semiconductor with a Buy and a $14 price target.
WIX Wix.com
$51.00

2.5 (5.15%)

11/11/16
JMPS
11/11/16
NO CHANGE
JMPS
Wix.com price target raised to $57 from $42 at JMP Securities
JMP Securities analyst Ronald Josey increased his price target on Wix.com after the company reported better than expected results that he calls "impressive." The analyst thinks that the company's new products will cause its revenue growth to continue to be strong. He reiterates an Outperform rating on the shares.
10/19/16
10/19/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DuPont (DD) initiated with a Buy at Nomura. 2. Square (SQ) initiated with a Neutral at Credit Suisse. 3. GoDaddy (GDDY) initiated with a Buy at Cantor. 4. Wix.com (WIX) was initiated with a Buy at Cantor while the firm initiated Web.com (WEB) initiated with a Hold. 5. Amarin (AMRN) initiated with a Buy at Citi. The firm has a $5 price target on the stock. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/18/16
CANT
10/18/16
INITIATION
Target $52
CANT
Buy
Wix.com initiated with a Buy at Cantor
Cantor initiated Wix.com with a Buy and a $52 price target.
09/23/16
RBCM
09/23/16
DOWNGRADE
RBCM
Sector Perform
Wix.com downgraded on valuation at RBC Capital
As noted earlier, RBC Capital downgraded Wix.com to Sector Perform from Outperform. Analyst Mark Mahaney downgraded the stock based on valuation. Target $45.
PLCM bought by Siris Capital 9/16

RDCM Radcom
$18.65

-0.1 (-0.53%)

09/26/16
NEED
09/26/16
NO CHANGE
Target $23
NEED
Buy
Radcom price target raised to $23 from $17 at Needham
Needham analyst Alex Henderson raised his price target for Radcom to $23 from $17 as the company delivers new customers and scales up. The analyst believes Radcom is a revenue story and continues to view investment in front of growth as essential which likely mitigates near-term EPS delivery. He reiterates a Buy rating on the shares.
05/23/16
NEED
05/23/16
INITIATION
Target $16
NEED
Buy
Radcom initiated with a Buy at Needham
Target $16.
SYNT Syntel
$20.93

0.01 (0.05%)

10/24/16
RHCO
10/24/16
DOWNGRADE
RHCO
Hold
Syntel downgraded to Hold from Buy at SunTrust
10/24/16
RHCO
10/24/16
DOWNGRADE
RHCO
Hold
Syntel downgraded on sector weakness at SunTrust
As noted earlier, SunTrust downgraded Syntel to Hold from Buy. Analyst Frank Atkins says that Syntel's results were disappointing and reveal "significant weakness" in its banking/financial services business. Target to $25 from $32.
10/05/16
BARD
10/05/16
NO CHANGE
Target $35
BARD
Outperform
Syntel beginning to look more interesting, says Baird
Baird analyst David Koning noted Syntel shares will begin trading ex-dividend after paying a $15 per share special dividend. The analyst is now viewing the shares as more interesting, noting they are selling at a discount to peers. Koning maintains his Neutral rating and has placed a new $35 price target on Syntel shares.
01/10/17
LOOP
01/10/17
INITIATION
Target $27
LOOP
Buy
Syntel initiated with a Buy at Loop Capital
Loop Capital analyst Joseph Vafi initiated Syntel with a Buy and a $27 price target.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

16:17
09/20/17
09/20
16:17
09/20/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
09/20/17
09/20
16:16
09/20/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$45.21

1.41 (3.22%)

16:16
09/20/17
09/20
16:16
09/20/17
16:16
Syndicate
Juno Therapeutics files $225M automatic stock shelf »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$156.07

-2.66 (-1.68%)

, BSTI

Best Inc.

16:16
09/20/17
09/20
16:16
09/20/17
16:16
General news
On The Fly: Top stock stories for Wednesday »

Stocks were largely on…

AAPL

Apple

$156.07

-2.66 (-1.68%)

BSTI

Best Inc.

BABA

Alibaba

$177.95

-2.12 (-1.18%)

FDX

FedEx

$220.53

4.531 (2.10%)

ADBE

Adobe

$149.96

-6.64 (-4.24%)

GIS

General Mills

$52.17

-3.215 (-5.81%)

CPRT

Copart

$33.86

1.32 (4.06%)

ALNY

Alnylam

$113.78

38.7408 (51.63%)

IONS

Ionis Pharmaceuticals

$53.88

-5.19 (-8.79%)

BBBY

Bed Bath & Beyond

$22.74

-4.29 (-15.87%)

DESP

Despegar.com

CELC

Celcuity

$14.29

14.289 (1,428,900.00%)

ZLAB

Zai Lab

KRYS

Krystal Biotech

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 22

    Oct

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

APC

Anadarko

$44.78

1.02 (2.33%)

16:15
09/20/17
09/20
16:15
09/20/17
16:15
Hot Stocks
Anadarko reaffirms production guidance »

"Separately, we want…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FCPT

Four Corners Property Trust

$25.32

0.02 (0.08%)

16:14
09/20/17
09/20
16:14
09/20/17
16:14
Hot Stocks
Four Corners Property Trust acquires 41 restaurant properties »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$44.79

1.03 (2.35%)

16:13
09/20/17
09/20
16:13
09/20/17
16:13
Hot Stocks
Anadarko targets $1B of of share repurchases prior to year-end 2017 »

Speaking about the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

TBPH

Theravance Biopharma

$33.07

0.49 (1.50%)

, GSK

GlaxoSmithKline

$40.17

0.25 (0.63%)

16:12
09/20/17
09/20
16:12
09/20/17
16:12
Hot Stocks
GlaxoSmithKline and Innoviva report positive Phase 3 results of Treleg Ellipta »

Theravance Biopharma…

TBPH

Theravance Biopharma

$33.07

0.49 (1.50%)

GSK

GlaxoSmithKline

$40.17

0.25 (0.63%)

INVA

Innoviva

$13.59

0.08 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 24

    Oct

APC

Anadarko

$44.79

1.025 (2.34%)

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Anadarko announces $2.5B share repurchase program »

Anadarko Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

QUAD

Quad/Graphics

$20.16

0.33 (1.66%)

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Quad/Graphics awarded $450M contract to print all Bluestem catalogs »

Quad/Graphics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

MLHR

Herman Miller

16:11
09/20/17
09/20
16:11
09/20/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Herman Miller »

Herman Miller reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

STBZ

State Bank Financial

$27.79

0.45 (1.65%)

16:08
09/20/17
09/20
16:08
09/20/17
16:08
Hot Stocks
FDIC approves State Bank Financial, AloStar merger transaction »

State Bank Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Hot Stocks
Herman Miller CEO says 'encouraged by the strong level of demand' »

Brian Walker, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

ARCC

Ares Capital

$15.85

0.035 (0.22%)

16:07
09/20/17
09/20
16:07
09/20/17
16:07
Initiation
Ares Capital initiated  »

Ares Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

16:06
09/20/17
09/20
16:06
09/20/17
16:06
Earnings
Herman Miller sees Q2 EPS 55c-61c, consensus 56c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MLHR

Herman Miller

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Earnings
Herman Miller reports Q1 adjusted EPS 57c, consensus 57c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

MDXG

MiMedx

$12.34

-0.82 (-6.23%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
MiMedx responds to two "deceptive short seller articles" »

MiMedx Group responded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

LUNA

Luna Innovations

$1.64

0.05 (3.14%)

16:05
09/20/17
09/20
16:05
09/20/17
16:05
Hot Stocks
Luna Innovations announces stock repurchase program »

Luna Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$53.40

-5.2 (-8.87%)

16:03
09/20/17
09/20
16:03
09/20/17
16:03
Hot Stocks
Aerie announces FDA Advisory Committee meeting for Rhopressa 0.02% »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Feb

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:57
09/20/17
09/20
15:57
09/20/17
15:57
Periodicals
Tesla working with AMD on self-driving car AI chip, CNBC says »

Tesla (TSLA) is using AMD…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

NVDA

Nvidia

$187.35

-0.2 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AMD

AMD

$13.12

0.04 (0.31%)

, TSLA

Tesla

$375.10

-9.9 (-2.57%)

15:54
09/20/17
09/20
15:54
09/20/17
15:54
Periodicals
Breaking Periodicals news story on AMD, Tesla »

Tesla working with AMD on…

AMD

AMD

$13.12

0.04 (0.31%)

TSLA

Tesla

$375.10

-9.9 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

15:50
09/20/17
09/20
15:50
09/20/17
15:50
General news
More from Yellen: »

More from Yellen: FOMC…

VIX

Volatility Index S&P 500 Options

15:40
09/20/17
09/20
15:40
09/20/17
15:40
Options
Active trading in VIX calls as players replace expiring positions »

Active trading in VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:35
09/20/17
09/20
15:35
09/20/17
15:35
General news
Yellen on the FRB »

Yellen on the FRB: she is…

DMPI

DelMar Pharmaceuticals

$1.12

0.0294 (2.70%)

15:33
09/20/17
09/20
15:33
09/20/17
15:33
Syndicate
DelMar Pharmaceuticals announces $10M registered direct offering at-the-market »

DelMar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.